Stock DNAC SOCL CAPI
Add to a list
To use this feature you must be a member
Log inSign up

SOCL CAPI Stock

Equities

DNAC

KYG8253W1096

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-24 pm EDT 		5-day change 1st Jan Change
2.71 USD +7.11% Intraday chart for SOCL CAPI -6.99% -72.46%
2022 Social Capital Suvretta Holdings Corp. III Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
2022 ProKidney Completes SPAC Merger With Social Capital Suvretta Holdings; Shares to Start Nasdaq Trading MT

Financials (USD)

Sales * - Sales 1 * - Capitalization 316M
Net income * - Net income 1 * - EV / Sales * -
Net cash position * - Net cash position 1 * - EV / Sales 1 * -
P/E ratio *
-
P/E ratio 1 *
-
Employees -
Yield *
-
Yield 1 *
-
Free-Float 0%
More Fundamentals * Assessed data

Chart SOCL CAPI

Dynamic Chart

Latest news about SOCL CAPI

Social Capital Suvretta Holdings Corp. III Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
ProKidney Completes SPAC Merger With Social Capital Suvretta Holdings; Shares to Start Nasdaq Trading MT
Social Capital Suvretta Holdings Corp. III(NasdaqCM:DNAC) dropped from NASDAQ Composite Index CI
ProKidney LLC completed the acquisition of Social Capital Suvretta Holdings Corp. III from SCS Sponsor III LLC, Millennium Management LLC, Adage Capital Management, L.P. and others in a reverse merger transaction. CI
Social Capital Suvretta Holdings Corp. III Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Social Capital Suvretta Holdings Corp. III Issues an Unsecured Promissory Note CI
Social Capital Suvretta Holdings Corp. III announced that it has received $1.5 million in funding from SCS Sponsor III LLC CI
Social Capital Suvretta Holdings Corp. III Reports Earnings Results for the Ten Months Ended December 31, 2021 CI
ProKidney to Become Publicly Traded via SPAC Merger With Social Capital Suvretta MT
Palihapitiya-backed SPAC to take biotech ProKidney public in $2.6 bln deal RE
Palihapitiya-backed SPAC to take ProKidney public in over $2 bln deal RE
ProKidney LLC executed the non-binding letter of intent to acquire Social Capital Suvretta Holdings Corp. III from SCS Sponsor III LLC, Millennium Management LLC, Adage Capital Management, L.P. and others in a reverse merger transaction. CI
Social Capital Suvretta Said in Merger Talks With Akili Interactive, ProKidney MT
Certain Class B Ordinary Shares of Social Capital Suvretta Holdings Corp. III are subject to a Lock-Up Agreement Ending on 27-DEC-2021. CI
Social Capital Suvretta Holdings Corp. III Reports Earnings Results for the Third Quarter and Seven Months Ended September 30, 2021 CI
More news

Press releases SOCL CAPI

SOCL CAPI : Revolutionary Chronic Kidney Disease Therapeutics Company ProKidney to List on the Nasdaq Following Business Combination with Social Capital Suvretta Holdings Corp. III - Form 8-K PU
Social Capital Suvretta III : Revolutionary Chronic Kidney Disease Therapeutics Company ProKidney to List on the Nasdaq Following Business Combination with Social Capital Suvretta Holdings Corp. III - Form 8-K PU
Revolutionary Chronic Kidney Disease Therapeutics Company ProKidney to List on the Nasdaq Following Business Combination with Social Capital Suvretta Holdings Corp. III AQ
Social Capital Suvretta III : Announces Reconvened Extraordinary General Meeting of Shareholders - Form 8-K PU
SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. III : Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K) AQ
More press releases

Quotes and Performance

1 day+7.11%
Current month-72.46%
Current year-72.46%
More quotes

Highs and lows

3 years
2.42
Extreme 2.42
11.98
5 years
2.42
Extreme 2.42
11.98
10 years
2.42
Extreme 2.42
11.98
More quotes

Quotes

Date Price Change Volume
24-04-24 2.71 +7.11% 530,630
24-04-23 2.53 -6.99% 1,152,575
24-04-22 2.72 +33.33% 2,804,606
24-04-19 2.04 -15.00% 783,634
24-04-18 2.4 -15.49% 1,505,649

Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT

More quotes

Company Profile

Social Capital Suvretta Holdings Corp. III is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It has not selected any specific business combination target and has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The Company intend to focus its search for a target business operating in the biotechnology industry and within the organ space subsector of such industry. The Company neither engages in any business operations nor generates any revenues.
Sector
-
More about the company
  1. Stock Market
  2. Equities
  3. DNAC Stock